Stonehearth Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Stonehearth Capital Management's PFE Position: Q3 2026 in Review
Stonehearth Capital Management reduced its Pfizer (PFE) stake by 5% in Q3 2026, selling an estimated $13.8K and leaving 9,929 shares worth $283K. The position accounts for 0.1% of the portfolio, ranked #68.
Stonehearth Capital Management first reported a position in PFE in Q2 2019 and has held it in 28 quarters since. The position peaked at $475K in Q2 2022. 2,887 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Stonehearth Capital Management held 9,929 shares of Pfizer worth $283K as of Q3 2026.
- Stonehearth Capital Management sold 519 Pfizer shares in Q3 2026, an estimated $13.8K.
- Pfizer made up 0.1% of Stonehearth Capital Management's portfolio in Q3 2026, its #68 holding.
- Stonehearth Capital Management first reported a position in Pfizer in Q2 2019 and has held it in 28 quarters since.
- Stonehearth Capital Management's Pfizer position peaked at $475K in Q2 2022.
- 2,887 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Stonehearth Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.